Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Nicholas Cost to Neoplasm Staging

This is a "connection" page, showing publications Nicholas Cost has written about Neoplasm Staging.

 
Connection Strength
  
 
 
2.684
  
  1. Saltzman AF, Smith DE, Gao D, Ghosh D, Amini A, Aldrink JH, Dasgupta R, Gow KW, Glick RD, Ehrlich PF, Cost NG. How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor. J Pediatr Surg. 2019 Nov; 54(11):2331-2335.
    View in: PubMed
    Score: 0.514
  2. Saltzman AF, Carrasco A, Maccini MA, Caldwell BT, Treece AL, Cost NG. Large Cystic Metanephric Adenoma in a 15-Year-Old Girl. Urology. 2017 Mar; 101:147-150.
    View in: PubMed
    Score: 0.433
  3. Walker JP, Han DS, Nicklawsky A, Boxley P, Morrison J, Tonzi M, Bruny J, Roach JP, Cost NG. Extended Lymph Node Sampling During Surgery for Pediatric Renal Tumors Concerning for Malignancy Does Not Increase Postoperative Complication Rates. J Urol. 2023 06; 209(6):1186-1193.
    View in: PubMed
    Score: 0.166
  4. Saltzman AF, Carrasco A, Amini A, Cost NG. Patterns of Care and Survival Comparison of Adult and Pediatric Wilms Tumor in the United States: A Study of the National Cancer Database. Urology. 2020 Jan; 135:50-56.
    View in: PubMed
    Score: 0.132
  5. Saltzman AF, Carrasco A, Amini A, Aldrink JH, Dasgupta R, Gow KW, Glick RD, Ehrlich PF, Cost NG. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database. J Pediatr Urol. 2018 04; 14(2):161.e1-161.e8.
    View in: PubMed
    Score: 0.115
  6. Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. J Pediatr Urol. 2017 Aug; 13(4):386.e1-386.e7.
    View in: PubMed
    Score: 0.109
  7. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 11; 97:138-144.
    View in: PubMed
    Score: 0.106
  8. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors. J Pediatr Hematol Oncol. 2015 Nov; 37(8):e441-6.
    View in: PubMed
    Score: 0.100
  9. Cost NG, Sawicz-Birkowska K, Kajbafzadeh AM, Tourchi A, Parigi GB, Guill?n G, DeFoor WR, Apoznanski W. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor. Urology. 2014 Jun; 83(6):1388-93.
    View in: PubMed
    Score: 0.090
  10. Cost NG, Maroni P, Flaig TW. Metastatic relapse after initial clinical stage I testicular Leydig cell tumor. Oncology (Williston Park). 2014 Mar; 28(3):211, 214.
    View in: PubMed
    Score: 0.089
  11. Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI, Margulis V. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy. Pediatr Blood Cancer. 2014 Mar; 61(3):446-51.
    View in: PubMed
    Score: 0.086
  12. Cost NG, Krabbe LM, Bagrodia A, Margulis V. The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. Curr Opin Urol. 2013 Sep; 23(5):411-7.
    View in: PubMed
    Score: 0.086
  13. Cost NG. Testicular germ cell tumors. Current concepts and management strategies. Minerva Urol Nefrol. 2013 Jun; 65(2):133-55.
    View in: PubMed
    Score: 0.085
  14. Rakheja D, Khokhar S, Mitui M, Cost NG. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors. Pediatr Dev Pathol. 2012 Jul-Aug; 15(4):286-92.
    View in: PubMed
    Score: 0.078
  15. Cost NG, Mitui M, Khokhar S, Wickiser JE, Baker LA, Rakheja D. TP53 codon 72 polymorphisms in favorable histology Wilms tumors. Pediatr Blood Cancer. 2012 Aug; 59(2):326-8.
    View in: PubMed
    Score: 0.075
  16. Cost NG, Lubahn JD, Granberg CF, Schlomer BJ, Wickiser JE, Rakheja D, Gargollo PC, Leonard D, Raj GV, Baker LA, Margulis V. Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor. Pediatr Blood Cancer. 2012 Jun; 58(6):898-904.
    View in: PubMed
    Score: 0.074
  17. Cost NG, Delacroix SE, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol. 2011 Jun; 59(6):912-8.
    View in: PubMed
    Score: 0.072
  18. Cost NG, Margulis V. Editorial comment. J Urol. 2011 Feb; 185(2):413; author reply 414.
    View in: PubMed
    Score: 0.071
  19. Aldrink JH, Romao R, Ehrlich PF, Tracy E, Kieran K, Davidoff A, Glick R, Malek M, Huntington J, Saltzman AF, Cost NG, Shamberger RC. Critical elements of radical nephroureterectomy for pediatric unilateral renal tumor. Semin Pediatr Surg. 2023 Oct; 32(5):151339.
    View in: PubMed
    Score: 0.044
  20. Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 12; 39(12):832.e9-832.e15.
    View in: PubMed
    Score: 0.036
  21. Halstead NV, Cost NG, Hecht SL, Walker JP. Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence. Urology. 2020 Mar; 137:168-172.
    View in: PubMed
    Score: 0.033
  22. Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, Geller JI, Ehrlich PF, Cost NG, Dome JS, Fernandez CV, Khanna G. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group. Pediatr Radiol. 2017 Nov; 47(12):1615-1621.
    View in: PubMed
    Score: 0.028
  23. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer. 2015 Jul 15; 121(14):2457-64.
    View in: PubMed
    Score: 0.024
  24. Lubahn JD, Cost NG, Kwon J, Powell JA, Yang M, Granberg CF, Wickiser JE, Rakheja D, Gargollo PC, Baker LA, Margulis V. Correlation between preoperative staging computerized tomography and pathological findings after nodal sampling in children with Wilms tumor. J Urol. 2012 Oct; 188(4 Suppl):1500-4.
    View in: PubMed
    Score: 0.020
  25. Margulis V, Master VA, Cost NG, Leibovich BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y, Rawal S, Chong TW, Wood CG. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Eur Urol. 2011 Oct; 60(4):673-83.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)